Related references
Note: Only part of the references are listed.Nanomaterials and nanoparticles: Sources and toxicity
Cristina Buzea et al.
BIOINTERPHASES (2007)
Translocation of inhaled ultrafine manganese oxide particles to the central nervous system
Alison Elder et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2006)
Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties
Ruchika Nijhara et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2006)
Acute toxicological effects of copper nanoparticles in vivo
Z Chen et al.
TOXICOLOGY LETTERS (2006)
Viral gene therapy strategies: from basic science to clinical application
LS Young et al.
JOURNAL OF PATHOLOGY (2006)
Nanoparticle-induced platelet aggregation and vascular thrombosis
A Radomski et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles
E Garcia-Garcia et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate
SH Kim et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Nanoparticles as carriers for nasal vaccine delivery
M Köping-Höggård et al.
EXPERT REVIEW OF VACCINES (2005)
Nanomedicine: current status and future prospects
SM Moghimi et al.
FASEB JOURNAL (2005)
Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines
P Arbós et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Drug delivery systems: Entering the mainstream
TM Allen et al.
SCIENCE (2004)
Nanoparticles of biodegradable polymers for clinical administration of paclitaxel
SS Feng et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Manufactured nanomaterials (Fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass
E Oberdörster
ENVIRONMENTAL HEALTH PERSPECTIVES (2004)
Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis
Y de Kozak et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses
M Diwan et al.
JOURNAL OF DRUG TARGETING (2004)
Nanotechnology and medicine
DF Emerich et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2003)
Selective bone cell adhesion on formulations containing carbon nanofibers
RL Price et al.
BIOMATERIALS (2003)
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
J Panyam et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A
MH El-Shabouri
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro
MEC Lutsiak et al.
PHARMACEUTICAL RESEARCH (2002)
Remote electronic control of DNA hybridization through inductive coupling to an attached metal nanocrystal antenna
K Hamad-Schifferli et al.
NATURE (2002)
Moving smaller in drug discovery and delivery
DA LaVan et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Protein nanoarrays generated by dip-pen nanolithography
KB Lee et al.
SCIENCE (2002)
Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics
MA Arangoa et al.
PHARMACEUTICAL RESEARCH (2001)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
